Figure 3.
Plotted estimates of adverse events cancer and rhabdomyolysis pooled from primary prevention trials on statin therapy. Pooled relative risk with bars representing 95% confidence intervals (CIs).
Notes: Adapted with permission from Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol. 2008;52(22):1769–1781.
